Terkko Navigator / -/ Feeds / " ( ( Huntingtonin tauti )|( huntingtons korea )|( Chorea Huntington )|( Huntingtonin kore"

Pepinemab antibody blockade of SEMA4D in early Huntington’s disease: a randomized, placebo-controlled, phase 2 trial

Perturbed actin cap and nuclear morphology in primary fibroblasts of Huntington's disease patients as a new phenotypic marker for personalized drug evaluation

Integrated transcriptome analysis of Huntingtons disease iPSC-derived and mouse astrocytes implicates dysregulated synaptogenesis, actin, and astrocyte maturation

Early Changes in Striatal Activity and Motor Kinematics in a Huntington's Disease Mouse Model

Huntington's disease transgenic mice are resistant to global cerebral ischemia.

Huntington’s disease: nearly four decades of human molecular genetics

Huntington's Disease Produces Multiplexed Transcriptional Vulnerabilities of StriatalD1-D2 and Striosome-Matrix Neurons

IJERPH, Vol. 18, Pages 5113: Genetic and Environmental Contributors to Neurodegeneration: An Exploration of the Effects of Alcohol on Clinical Features of Huntington’s Disease Using the Enroll-HD Global Platform

SorCS2 dynamically interacts with TrkB and GluN2B to control neurotransmission and Huntington's disease progression

Role of defective calcium regulation in cardiorespiratory dysfunction in Huntington’s disease

Bioinformatic gene analysis for potential therapeutic targets of Huntington’s disease in pre-symptomatic and symptomatic stage

Study: Optogenetic stimulation of circuit improves symptomatology of Huntington's disease

Transposable Element activation promotes neurodegeneration in a Drosophila model of Huntington's disease

Cells, Vol. 10, Pages 1565: Cell Reprogramming to Model Huntington’s Disease: A Comprehensive Review

JCM, Vol. 10, Pages 3001: Is TGF-β1 a Biomarker of Huntington’s Disease Progression?

A novel imaging ligand as a biomarker for mutant huntingtin-lowering in Huntington's disease

JPM, Vol. 11, Pages 714: High Frequency of Concomitant Bladder, Bowel, and Sexual Symptoms in Huntington’s Disease: A Self-Reported Questionnaire Study

Antioxidants, Vol. 10, Pages 1468: Signaling Overlap between the Golgi Stress Response and Cysteine Metabolism in Huntington’s Disease

Striatal compartmentalization and clustering of different subtypes of astrocytes is altered in the zQ175 Huntington's disease mouse model

Skeletal muscle regeneration is altered in the R6/2 mouse model of Huntington's disease

Ribotoxic collisions on CAG expansions disrupt proteostasis and stress responses in Huntington's Disease

Proteomic Analysis of Huntington's Disease Medium Spiny Neurons Identifies Alterations in Lipid Droplets

CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in huntington’s disease

Rhes Deletion Prevents Age-Dependent Selective Motor Deficits and Reduces Phosphorylation of S6K in Huntington Disease Hdh150Q(CAG) Knock-In Mice.

JCM, Vol. 11, Pages 2110: Neural Network Aided Detection of Huntington Disease

Loss of Hap1 selectively promotes striatal degeneration in Huntington disease mice [Neuroscience]

The distribution and density of Huntingtin inclusions across the Huntington disease neocortex: regional correlations with Huntingtin repeat expansion independent of pathologic grade

Återkommande psykotiska symtom under många år var Huntingtons sjukdom

Förväxling av prov för Huntingtons sjukdom: Säkrare rutiner behövs

The structural involvement of the cingulate cortex in premanifest and early Huntington's disease

Atypical Huntington's disease with the clinical presentation of behavioural variant of frontotemporal dementia.

Management of Agitation in Huntington's Disease: A Review of the Literature.

A Rationale for Hypoxic and Chemical Conditioning in Huntington's Disease.

Atypical Huntington's disease with the clinical presentation of behavioural variant of frontotemporal dementia

Protocol for an open label: phase I trial within a cohort of foetal cell transplants in people with Huntington’s disease

Investigating longitudinal changes to frontal cortico-striatal tracts in Huntington’s disease: the IMAGE-HD study

Behavioral Deficits in Juvenile Onset Huntington's Disease.

Dysphagia characteristics in Huntington's disease patients: insights from the Fiberoptic Endoscopic Evaluation of Swallowing and the Swallowing Disturbances Questionnaire.

The Association between CAG Repeat Length and Age of Onset of Juvenile-Onset Huntington's Disease.

Implications of the Orb2 Amyloid Structure in Huntington's Disease.

Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical Trial.

Development of Hippocampus-Associated Cognitive Dysfunction in Huntington’s Disease Mouse Model

Predicting clinical scores in Huntington’s disease: a lightweight speech test

Computational insights into missense mutations in HTT gene causing Huntington's disease and its interactome networks

Epidemiology of Huntington's disease in Finland.

Epidemiology of Huntington's disease in Finland.

Early Retinal Function Deficit without Prominent Morphological Changes in the R6/2 Mouse Model of Huntington's Disease.

Epidemiology of stroke in Finnish patients with Huntington's disease.

Comorbid epilepsy in Finnish patients with adult-onset Huntington's disease.

Chronic subdural hematomas in Finnish patients with Huntington's disease.